Barry D Quart sold $684K of Kiniksa Pharmaceuticals International (KNSA)

Executed Feb 3, disclosed Feb 4, 1 day later.

Value, as filed

$684K

15,130 sh across 2 lots

Executed

Feb 3

the trade date, as filed

Disclosed

Feb 4

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Barry D Quart Director profile →

Barry D Quart (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $836K of KNSA (20,129 sh × $41.51, as filed), executed Dec 15 2025.

The name

KNSA

Kiniksa Pharmaceuticals International, plc KNSA · Healthcare · 68 filings in 24 months ticker →

Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Barry D Quart in KNSA

KNSASALE Kiniksa Pharmaceuticals International, plc $656K
13,099 sh × $50.10
Exec Apr 28
Filed Apr 29 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $345K
6,901 sh × $50.00
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $121K
2,690 sh × $45.00
Exec Feb 12
Filed Feb 12 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $836K
20,129 sh × $41.51
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $833K
27,448 sh across 3 lots
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET